SUMMARY Circulating immune complexes have been detected in patients with inflammatory bowel disease (IBD). To determine if these complexes are related specificially to IBD or more generally to loss of intestinal mucosal integrity, we compared circulating immune complex levels in the sera of 86 IBD patients, nine pseudomembranous and nine bacterial colitis patients, and 42 healthy controls. Immune complexes were measured by a Raji cell radioimmunoassay. Raji detectable circulating immune complex levels were significantly higher in the IBD group than in the healthy controls (P<0001). Circulating immune complex levels in the pseudomembranous-bacterial colitis group and the healthy controls were essentially identical. While nearly 20 % of the IBD patients (16 of 86) had abnormally high levels, none of the patients with the other forms of intestinal inflammation (0 of 18) had abnormal levels. These data suggest that the circulating immune complexes present in inflammatory bowel disease patients are related to the IBD process rather than to non-specific mucosal cell (barrier) damage. Patients with intestinal inflammation and normal peripheral immune complex levels also had normal mesenteric vein levels. These data suggest that lack of formation, rather than more efficient hepatic reticuloendothelial clearance, was primarily responsible for the absence of detectable complexes in Raji negative individuals. Circulating immune complex levels did not correlate with type,
Circulating immune complexes (CIC) Received for publication 16 October 1979 previous investigators to examine patients with otherforms of intestinal inflammation resulting in mucosal denudation for the presence of CIC.
A determination of whether the circulating complexes are related to loss of mucosal integrity in general, or to inflammatory bowel disease in particular, is of considerable importance. A demonstration that circulating immune complexes occur with non-specific inflammation would suggest strongly that they are not of pathogenic significance in IBD. On the other hand, the demonstration that such complexes are related specificially to idiopathic inflammatory bowel disease, while not necessarily denoting pathogenic significance, would indicate that the complexes may be employed to isolate,, characterise, and identify disease specific antigens.
Such antigens, even in non-pathogenic complexes, may prove to be of aetiological or diagnostic significance.
In the present study the relationship of circulating immune complexes to inflammatory bowel disease was examined by comparing levels present in the sera of IBD patients with levels present in the sera of patients having prolonged active pseudomembranous or bacterial colitis. A sensitive Raji cell radioimmunoassay was used to detect complexes. The relationship between CIC levels and disease status, and the role of the hepatic reticuloendothelial system in determining the presence of peripheral circulating immune complexes were also examined.
Methods
Eighty-six patients with inflammatory bowel disease comprised one study group (group I). Thirty-two ulcerative colitis (UC), 11 Eleven patients were receiving parenteral hyperalimentation and were without oral intake for one week or longer before blood sampling. Three of these patients had raised levels of Raji detectable circulating immune complexes.
Seventeen IBD patients had resection of diseased portions of their intestine and bloods were obtained two weeks after surgery in 15 cases. The mean CIC level in the peripheral sera of this group was identical with the healthy control mean. Only one of the patients had an abnormally high post-resection value (Fig. 4) 
Discussion
Circulating immune complexes have been detected in patients with inflammatory bowel disease'-6. We compared circulating immune complex levels in patients with inflammatory bowel disease with levels in patients having prolonged active pseudomembranous or bacterial colitis, to determine if complexes are related specifically to IBD or more generally to loss of intestinal mucosal integrity.
Our data show that, while the mean CIC level for the IBD group was significantly higher, the mean level for the pseudomembranous and bacterial colitis group was essentially identical with that obtained for the healthy control population. Furthermore, while nearly 20% of the IBD patients, including those without oral intake, had values above the normal range none of the patients with pseudomembranous or bacterial colitis had abnormal levels. These data strongly suggest that the rises in Raji detectable CIC are related to IBD rather than to a non-specific loss of mucosal integrity.
Although the duration of the mucosal defects in the IBD and patient control groups were dissimilar, this difference probably does not account for the disparity in immune complex levels. All the pseudomembranous colitis patients had documented disease for 10 days or longer and the bacterial colitis patients had active disease for approximately one week. Based on experiments in animals suggesting that peak circulating immune complexes occur between the seventh and 10th day of repeated antigen exposure,13 it seems probable that the control group would have had sufficient time to allow CIC formation, if production of complexes were solely the result of repeated exposure to luminal antigens. In addition, there was no discernable correlation between the duration of IBD and the presence of CIC abnormalities.
A previous investigation was able to demonstrate large circulating immune complexes only in those IBD patients having concomitant liver disease.3 These data have raised the possibility that raised peripheral blood levels reflect a failure of certain IBD patients to clear immune complexes generally entering the portal system secondary to mucosal damage, rather than the formation of specific complexes in IBD. In our study, however, 13 of 16 IBD patients with raised CIC had normal liver function tests. Furthermore, the normal mesenteric vein levels in 11 patients with documented intestinal inflammation suggest that Raji detectable immune complexes do not routinely enter the portal system as a consequence of bowel inflammation and that peripheral levels reflect differential production and not hepatic clearance.
Many investigators have felt that CIC have been detected previously in only a fraction of IBD patients because of the relative insensitivities of the assays used to measure such complexes. In the present investigation, we used a sensitive Raji cell radioimmunoassay capable of detecting a wide range of complement fixing complexes with greater sensitivity than many other complement-dependent systems.1415 The detection of immune complexes in the peripheral circulation in only 20% of the IBD patients studied with his more sensitive assay suggests that assay sensitivity, if it is involved, is not the sole factor responsible for the inability to detect CIC in more patients with inflammatory bowel disease.
Occurrence of immune complexes may be underestimated because indirect assays for circulating immune complexes generally measure limited subpopulations of complexes.'6 Incomplete overlap of these subpopulations34 means that the number of patients positive for CIC by one assay are partially additive to those positive by another indirect technique. Additionally, underestimation of the frequency of CIC in IBD may result from examination for complexes at a single time point in the course of disease. Relative antigen/antibody concentrations, critical in the detection of complexes, are likely to fluctuate through the course of the illness.
Immune complexes administered to rabbits intravenously have been shown to localise in traumatically inflamed intestinal mucosa.17 This observation has led to the hypothesis that IBD may involve formation of CIC in response to 'non-intestinal' antigen(s), and preferential deposition of these complexes in intestinal tissue made susceptible by non-specific inflammation. If this were the case, one would expect resection of the inflamed bowel to result in raised CIC levels. In the present study, only one of the IBD patients had raised levels after a resection, and a coexistent sternal abscess was believed to be the source of the CIC in that patient. Similarly, Fiasse et al.6 found the lowest incidence of CIC in their group of patients with bowel resections. Both findings implicate the bowel as the source rather than the site of deposition of systemically formed complexes.
Comparison of CIC levels found in groups of patients with different disease activity and examination of levels in individual patients during different stages of disease failed to demonstrate a correlation between disease severity and immune complex levels. Although some studies have reported a correlation between CIC levels and changes in disease status in individual patients, most studies have been generally unsuccessful in demonstrating statistically significant relationships between CIC levels and severity of disease.24 Such a relationship does not appear to be masked by the more frequent use of steroids in severe cases, as our data show no correlation between steroid administration and CIC levels. The failure of peripheral CIC levels to correlate with disease activity does not necessarily preclude pathogenic significance for such complexes. The absence of more marked rises of CIC in severe disease could, in fact, reflect increased tissue deposition with resultant intestinal injury. Alternatively, an increase in antigen formation or release occurring with severe disease may result in marked antigen excess and thus the formation of complexes which are poorly detected by indirect assays. '314 Patients with CIC in our study did not have a higher incidence of extraintestinal manifestations than IBD patients without such complexes, in contrast to a recent report.3 Although differences in the populations of complexes measured by the different assays may be responsible for the discrepant findings, it is equally likely that there was a difference in the populations studied. Many of the patients with extraintestinal complications reported by Hodgson et al.3 had liver disease. As various forms of liver disease result in immune complex production," 14 18 19 their data may reflect the production of liver disease associated complexes, rather than inflammatory bowel disease related CIC. Regardless of the cause of the above disparity, the absence of CIC in 46 per cent 
